GO:0140298 endocytic iron import into cell

Endocytic iron import into cell (GO:0140298) is the biological process by which a cell takes up iron through binding of an extracellular iron carrier to a receptor, followed by internalization of the receptor-ligand complex via endocytosis. This process is essential for cellular iron homeostasis, as iron is required for oxygen transport, DNA synthesis, and mitochondrial respiration, but free iron can also catalyze harmful oxidative reactions. The transferrin receptor pathway is the best-characterized route for endocytic iron import in mammalian cells, and its dynamics are especially important during rapid proliferation and immune activation. In T cells, a rapid increase in transferrin receptor recycling promotes adhesion during activation, demonstrating that endocytic iron import is not merely a housekeeping function but is integrated with cell adhesion and signaling. Beyond mammalian cells, endocytic iron import is conserved across evolution. In fungi, endocytosis of nutrient transporters, including iron transporters, connects signaling and trafficking pathways that determine how cells adapt to changing nutrient environments. In the enteric parasite Entamoeba histolytica, endosomal maturation of human holo-transferrin depends on Rab5 and Rab7A, which are essential for biogenesis of giant early endocytic vacuoles. These examples show that the core machinery of endocytic iron import is ancient and can be repurposed for specialized physiological needs. Dysregulation of endocytic iron import is increasingly linked to human disease. Post-translational changes to alpha-synuclein control iron and dopamine trafficking, suggesting a concept for neuron vulnerability in Parkinson's disease. Moreover, alpha-synuclein inhibits Snx3-retromer-mediated retrograde recycling of iron transporters in S. cerevisiae and C. elegans models of Parkinson's disease, directly tying this process to neurodegeneration. For researchers, GO:0140298 provides a precise framework to study how cells acquire iron, how this process is regulated, and how it can be targeted in cancer, infection, and neurodegenerative disease.

GO:0140298 endocytic iron import into cell is defined as the uptake of iron into a cell via binding to an extracellular receptor, which is internalized by endocytosis. In other words, iron is not transported directly across the plasma membrane as a free ion; instead, it is carried by an extracellular protein such as transferrin, binds to a specific cell-surface receptor, and is brought into the cell inside an endocytic vesicle. This definition distinguishes endocytic iron import from other iron uptake mechanisms, such as direct metal ion transport or non-receptor-mediated processes. The term is a biological process and is synonymous with iron import into cell by endocytosis.

Endocytic iron import into cell is important because iron is indispensable for cell proliferation, metabolism, and oxygen transport, yet free iron is toxic. The transferrin receptor pathway allows cells to acquire iron safely and rapidly, and its regulation is critical during immune activation, where increased transferrin receptor recycling supports T cell adhesion and function. In fungi, endocytosis of nutrient transporters controls signaling and trafficking, showing that this process is a hub for environmental adaptation. In neurodegenerative disease, alpha-synuclein post-translational changes alter iron and dopamine trafficking, and alpha-synuclein inhibits Snx3-retromer-mediated recycling of iron transporters, directly linking endocytic iron import to Parkinson's disease pathology [3,4]. In parasitic infections, endosomal maturation of holo-transferrin via Rab5 and Rab7A is essential for Entamoeba histolytica, highlighting the process as a potential therapeutic target.

The following genes and proteins are experimentally implicated in endocytic iron import into cell (GO:0140298) based on the verified literature.

Endocytic iron import into cell is regulated at multiple levels. In T cells, transferrin receptor recycling rapidly increases during activation, promoting adhesion and sustaining iron uptake. In fungi, endocytosis of nutrient transporters is controlled by signaling pathways that connect environmental cues to trafficking decisions. In Parkinson's disease models, alpha-synuclein post-translational changes control iron and dopamine trafficking, and alpha-synuclein inhibits Snx3-retromer-mediated retrograde recycling of iron transporters, thereby dysregulating iron import [3,4]. In Entamoeba histolytica, Rab5 and Rab7A are essential for endosomal maturation of holo-transferrin, indicating that small GTPase-dependent trafficking is a key regulatory layer.

Endocytic iron import is directly linked to Parkinson's disease through alpha-synuclein. Post-translational changes to alpha-synuclein control iron and dopamine trafficking, suggesting a mechanism for neuron vulnerability. Moreover, alpha-synuclein inhibits Snx3-retromer-mediated retrograde recycling of iron transporters in S. cerevisiae and C. elegans models of Parkinson's disease, leading to iron dyshomeostasis. These findings indicate that disrupting the recycling arm of endocytic iron import contributes to neurodegeneration.

Proliferating cells have high iron demands, and the transferrin receptor pathway is a major route for endocytic iron import. Rapid transferrin receptor recycling supports T cell activation and adhesion, and similar mechanisms may operate in cancer cells to sustain growth. Targeting endocytic iron import is therefore an attractive strategy for cancer therapy, as it could limit iron availability to tumor cells.

In the enteric parasite Entamoeba histolytica, endosomal maturation of human holo-transferrin requires Rab5 and Rab7A for biogenesis of giant early endocytic vacuoles. This dependence on host iron uptake machinery highlights endocytic iron import as a potential target for antiparasitic drugs. In fungi, endocytosis of nutrient transporters is also critical for survival and adaptation, offering another avenue for antifungal development.

Fluorescence microscopy and live-cell imaging can track transferrin receptor internalization and recycling. In T cells, rapid transferrin receptor recycling can be visualized to study adhesion during activation. In Entamoeba histolytica, imaging of giant early endocytic vacuoles reveals the roles of Rab5 and Rab7A in holo-transferrin maturation.

CRISPR knockout, knock-in, and point mutation models allow precise dissection of genes involved in endocytic iron import. For example, TFRC knockout can test dependence on transferrin receptor, while SNCA point mutations can mimic Parkinson's disease-associated changes [3,4]. RAB5 and RAB7A knockouts in Entamoeba histolytica can reveal their essential roles in endosomal maturation.

Iron uptake can be measured using radiolabeled or fluorescent iron carriers. Transferrin binding and internalization assays quantify the rate of endocytic iron import. In fungal systems, endocytosis of nutrient transporters can be monitored by following transporter trafficking and degradation.

Proteomic approaches can identify proteins associated with endocytic vesicles and recycling endosomes. In Parkinson's disease models, interactomics can reveal how alpha-synuclein affects Snx3-retromer-mediated recycling of iron transporters. Such studies help map the molecular machinery of GO:0140298.

Researchers studying endocytic iron import into cell-related genes often need to determine whether a candidate gene is causally involved in receptor binding, internalization, endosomal maturation, or recycling. EDITGENE provides CRISPR-based cell models and screening services to interrogate every step of GO:0140298 with precision.

GO:0140298 endocytic iron import into cell is a fundamental biological process that supplies cells with iron through receptor-mediated endocytosis. Its core machinery, including transferrin receptor, Rab5, Rab7A, and retromer components, is conserved and tightly regulated, with direct implications for immune activation, Parkinson's disease, cancer, and parasitic infections [1,2,3,4,5]. Studying this process with CRISPR-based models and advanced imaging will continue to reveal how cells balance iron uptake with disease risk.